427 related articles for article (PubMed ID: 28526303)
1. The use of Biobrane
Rogers AD; Blackport E; Cartotto R
Burns; 2017 Nov; 43(7):1464-1472. PubMed ID: 28526303
[TBL] [Abstract][Full Text] [Related]
2. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
[TBL] [Abstract][Full Text] [Related]
3. The use of porcine xenografts in patients with toxic epidermal necrolysis.
Young JB; Gondek SP; Troche M; Summitt JB; Rae L; Thayer WP; Kahn SA
Burns; 2016 Dec; 42(8):1728-1733. PubMed ID: 27350163
[TBL] [Abstract][Full Text] [Related]
4. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
[TBL] [Abstract][Full Text] [Related]
5. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
McCullough M; Burg M; Lin E; Peng D; Garner W
Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
[TBL] [Abstract][Full Text] [Related]
6. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
[TBL] [Abstract][Full Text] [Related]
7. Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome.
Davis JS; Pandya RK; Pizano LR; Namias N; Dearwater S; Schulman CI
J Burn Care Res; 2013; 34(5):492-7. PubMed ID: 23966120
[TBL] [Abstract][Full Text] [Related]
8. Toxic epidermal necrolysis: a review and report of the successful use of Biobrane for early wound coverage.
Bradley T; Brown RE; Kucan JO; Smoot EC; Hussmann J
Ann Plast Surg; 1995 Aug; 35(2):124-32. PubMed ID: 7486733
[TBL] [Abstract][Full Text] [Related]
9. Antishear Therapy for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Follow-up Study.
Haravu PN; Gottlieb LJ; Vrouwe SQ
J Burn Care Res; 2021 Nov; 42(6):1152-1161. PubMed ID: 34370855
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Patients Treated With a Medicine-Led Multidisciplinary Approach.
Lewcun JA; Vagonis A; Kontzias C; Newsom M; Drake M; Feldman MJ
J Burn Care Res; 2024 Jan; 45(1):165-168. PubMed ID: 37698266
[TBL] [Abstract][Full Text] [Related]
11. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
13. Biobrane versus topical agents in the treatment of adult scald burns.
Krezdorn N; Könneker S; Paprottka FJ; Tapking C; Mett TR; Brölsch GF; Boyce M; Ipaktchi R; Vogt PM
Burns; 2017 Feb; 43(1):195-199. PubMed ID: 27507189
[TBL] [Abstract][Full Text] [Related]
14. Use of Biobrane in the treatment of toxic epidermal necrolysis.
Kucan JO
J Burn Care Rehabil; 1995; 16(3 Pt 1):324-7; discussion 327-8. PubMed ID: 7673317
[TBL] [Abstract][Full Text] [Related]
15. Role of nanocrystalline silver dressings in the management of toxic epidermal necrolysis (TEN) and TEN/Stevens-Johnson syndrome overlap.
Smith SD; Dodds A; Dixit S; Cooper A
Australas J Dermatol; 2015 Nov; 56(4):298-302. PubMed ID: 25368980
[TBL] [Abstract][Full Text] [Related]
16. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit.
Houschyar KS; Tapking C; Borrelli MR; Nietzschmann I; Puladi B; Ooms M; Rein S; Houschyar M; Duscher D; Maan ZN; Reumuth G; Branski LK; Modabber A; Kluwig D; Schmitt L; Philipp-Dormston WG; Yazdi AS; Siemers F
J Wound Care; 2021 Jun; 30(6):492-496. PubMed ID: 34121430
[TBL] [Abstract][Full Text] [Related]
17. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
[TBL] [Abstract][Full Text] [Related]
18. Differences in Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at Burn Centers and Nonburn Centers.
Nygaard RM; Endorf FW
J Burn Care Res; 2020 Sep; 41(5):945-950. PubMed ID: 32498082
[TBL] [Abstract][Full Text] [Related]
19. Biobrane wound dressing used in the treatment of toxic epidermal necrolysis: a case report.
Sowder LL
J Burn Care Rehabil; 1990; 11(3):237-9. PubMed ID: 2373732
[TBL] [Abstract][Full Text] [Related]
20. A prospective clinical trial comparing Biobrane(®) Dressilk(®) and PolyMem(®) dressings on partial-thickness skin graft donor sites.
Schulz A; Depner C; Lefering R; Kricheldorff J; Kästner S; Fuchs PC; Demir E
Burns; 2016 Mar; 42(2):345-55. PubMed ID: 25720659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
